Single Low-Dose of Supplement Amino Acid

Pennington Biomedical Research Center

Status: Completed

Conditions: Growth Hormone; Amino Acid

Treatments: Drug: Placebo; Drug: Amino acid supplement

Study type: Interventional

Funder types: Other

Identifiers

NCT01540773

PBRC 10043

Details and patient eligibility

About

The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.

Full description

Oral supplementation with a key combination of derivatives that has been shown to increase human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours post-administration.

Enrollment: 16 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• healthy males and healthy females
• Between 18 and 70 years

Exclusion criteria

• Pregnant or nursing
• Taking any chronic medication including birth control pills.

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

16 participants in 2 patient groups, including a placebo group

amino acid supplement

Active Comparator group

Description:

supplements with the proprietary amino acid derivative blend.

Treatment:

Drug: Amino acid supplement

Placebo

Placebo Comparator group

Description:

Non-Active

Treatment:

Drug: Placebo